Genmab holds extraordinary general meeting
GMAB•Genmab held an extraordinary general meeting on Oct. 7, 2026, where shareholders adopted the board’s 2026 remuneration proposal. The resolution triggered grants of 5,300 restricted stock units, each valued at DKK 2,487 at grant.
1. Board remuneration approved
Shareholders adopted Genmab’s 2026 board remuneration proposal, which includes share-based pay through restricted stock units. Each unit carries a conditional right to one Genmab share and is scheduled to vest after three years, on the first banking day of the following month.
